Superior Planning LLC’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$244 Buy
+17
New +$292 ﹤0.01% 2016

Other funds holding TRVI

Superior Planning LLC's TRVI Position: Q3 2026 in Review

Superior Planning LLC opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 17 shares worth $244. The stake represents ﹤0.01% of the portfolio and ranks #2016 among its holdings.

160 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

  • Superior Planning LLC held 17 shares of Trevi Therapeutics worth $244 as of Q3 2026.
  • Trevi Therapeutics was a new Superior Planning LLC position in Q3 2026.
  • Trevi Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #2016 holding.
  • 160 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.